Immunoprecise Antibodies Ltd (IPA) - News Archive

Victoria, British Columbia - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (IPA or the Company) has announced significant developments in both its financial reporting schedule and product offerings. Below, we outline the...

IPAs Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai VICTORIA, British Columbia - ImmunoPrecise Antibodies Ltd. (IPA)...

BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), has recently launched a groundbreaking software called LENSai API for AI-driven drug discovery. This advanced software solution, based on artificia...

InterSystems and IPA s Subsidiary BioStrand Collaborate to Revolutionize AI-Driven Healthcare ApplicationsVICTORIA, British Columbia - InterSystems and the subsidiary BioStrand of ImmunoPrecise Antibodies Ltd. (IPA) are...

VICTORIA, British Columbia - Immunoprecise Antibodies Ltd. (IPA), an artificial intelligence-driven biotherapeutic research and technology company, has recently announced its acquisition of the LSA instrument platform f...

IPA Announces Successful Completion of $1.265 Million Public Offering of Common SharesVictoria, British Columbia - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) or IPA, recently released news of the closure of its underwr...

IPA Announces Proposal for Public Offering of Ordinary Shares in Victoria, British ColumbiaImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), also known as ImmunoPrecise or IPA, has recently announced its plans to offer and s...

IPA Announces Proposed Public Offering of Common SharesVICTORIA, British Columbia - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (ImmunoPrecise or IPA or the Company), a leading provider of custom antibody development an...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is excited to announce significant changes within its Board of Directors and the anticipated release of its second-quarter 2024 earnings report. With a strong focus on AI-driv...

Revolutionizing Biological Sequence Retrieval: BioStrand s Innovative Fusion of Natural Language Processing and Database ResearchIn a groundbreaking development, BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd....

IPA Expands Growth Strategy Amid Recent Market DevelopmentsVICTORIA, British Columbia - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is providing an update on...